| |
Arthritis News Archive11-Aug-2008
Australian scientists in potential leukaemia breakthrough (TODAYonline)
A woman donating blood. Australian scientists said Monday they had mapped a blood cell structure which could hold the key to improved drug treatments for diseases such as leukaemia, asthma and rheumatoid arthritis
New treatment in the pipeline for leukaemia and rheumatoid arthritis (News-Medical-Net)
Australian scientists believe they are well on the way to developing a new treatment for leukaemia and inflammatory diseases such as rheumatoid arthritis and asthma.
Tools can provide a better grip on living with arthritis (The Providence Journal)
Lisa Bielstein knows that arthritis can make simple things, such as opening a jar or pruning a rose, a painful experience.
Australian scientists in potential leukaemia breakthrough (AFP via Yahoo! News)
Australian scientists said Monday they had mapped a blood cell structure which could hold the key to improved drug treatments for diseases such as leukaemia, asthma and rheumatoid arthritis.
News' Hamilton a true pioneer (Deseret Morning News)
Some days I wish I could stop the relentless march of time. My children are outgrowing me. My dog is developing arthritis. My grandfather is becoming forgetful. And my parents, well, they're just getting old. And now I must face the loss of Linda.
Psoriasis and arthritis ? are they linked? (The Star)
Between 10-15% of patients with psoriasis develop psoriatic arthritis.
Patients find a way to share feelings online (The Times-News)
WASHINGTON - Susan Rutherford needed to share her pain. The 43-year-old Philadelphia-area mother with rheumatoid arthritis, a chronic disease that causes severe swelling and pain in the joints, turned to the Web to seek out counsel.
Hollis-Eden begins phase I/II trial of Triolex for rheumatoid arthritis (PharmaBiz)
Hollis-Eden Pharmaceuticals, the world leader in the development of a new class of small molecule compounds based on endogenous adrenal steroid hormones, has commenced phase I/II open label dose ranging clinical trial with its investigational oral drug candidate Triolex (HE3286) in patients diagnosed with rheumatoid arthritis (RA) and receiving a stable dose of methotrexate, the current standard ...
Back to Alternative Treatments for Arthritis
Back to Arthritis News Archive
|
|
|